Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells.

Lin, Hui-Ping

Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells. [electronic resource] - Phytotherapy research : PTR Jan 2012 - 122-6 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1099-1573

10.1002/ptr.3523 doi


Antineoplastic Agents--pharmacology
Biological Availability
Caffeic Acids--pharmacology
Carcinoma, Non-Small-Cell Lung--drug therapy
Cell Line, Tumor
Cell Proliferation--drug effects
Chromones--pharmacology
Curcuma--chemistry
Curcumin--pharmacology
Drug Therapy, Combination
Enzyme Inhibitors--pharmacology
ErbB Receptors--antagonists & inhibitors
Humans
Morpholines--pharmacology
NF-kappa B--antagonists & inhibitors
Phenylethyl Alcohol--analogs & derivatives
Phosphoinositide-3 Kinase Inhibitors
Phytotherapy
Plant Extracts--pharmacology
Pyrimidines--pharmacology
Quinazolines--pharmacology
Receptors, Fibroblast Growth Factor--antagonists & inhibitors
Signal Transduction--drug effects
Somatomedins--antagonists & inhibitors
Tyrphostins--pharmacology